The counter opened at Rs 323.65 and touched an intraday high and low of Rs 329.9 and Rs 320.2, respectively, in the session so far. The stock of Biocon Ltd. quoted a 52-week high of Rs 487.7 and a 52-week low of Rs 314.9.
Total market cap of the Biocon Ltd. stood at Rs 39559.77 crore at the time of writing this report.
Key Financials
The company reported consolidated sales of Rs 1945.3 crore for the quarter ended 30-Sep-2021, up 7.61 per cent from previous quarter’s Rs 1807.8 crore and up 10.51 per cent from the year-ago quarter’s Rs 1760.3 crore.
The net profit for latest quarter stood at Rs 138.3 crore, down 18.31 per cent from the corresponding quarter last year.
Shareholding pattern
As of 30-Sep-2021, domestic institutional investors held 2.58 per cent stake in the company, while foreign institutional investors held 16.3 per cent and the promoters 60.64 per cent.
Valuation ratio
According to BSE data, the stock traded at a price-to-earnings multiple of 61.38 and a price-to-book ratio of 6.51. A higher P/E ratio shows investors are willing to pay a higher price because of better future growth expectations. Price-to-book value indicates the inherent value of a company and is the measure of the price that investors are ready to pay even for no growth in the business.
Biocon Ltd. belongs to the Pharma – Indian industry.
